Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
525 | 17362 | 33.8 | 77% |
Classes in level above (level 4) |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
869 | 10864 | LIPODYSTROPHY//HIV ASSOCIATED NEPHROPATHY//LIPOATROPHY |
1620 | 6498 | PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII PNEUMONIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LIPODYSTROPHY | Author keyword | 338 | 54% | 3% | 439 |
2 | PNEUMOCYSTIS CARINII | Author keyword | 289 | 66% | 2% | 267 |
3 | PNEUMOCYSTIS JIROVECII | Author keyword | 236 | 86% | 1% | 121 |
4 | PNEUMOCYSTIS CARINII PNEUMONIA | Author keyword | 164 | 58% | 1% | 188 |
5 | PNEUMOCYSTIS PNEUMONIA | Author keyword | 158 | 74% | 1% | 116 |
6 | PNEUMOCYSTIS | Author keyword | 139 | 70% | 1% | 117 |
7 | HIV INFECTION | Author keyword | 113 | 16% | 4% | 639 |
8 | HIV ASSOCIATED NEPHROPATHY | Author keyword | 110 | 78% | 0% | 72 |
9 | ANTIRETROVIRAL THERAPY | Author keyword | 83 | 14% | 3% | 573 |
10 | LIPOATROPHY | Author keyword | 82 | 53% | 1% | 110 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPODYSTROPHY | 338 | 54% | 3% | 439 | Search LIPODYSTROPHY | Search LIPODYSTROPHY |
2 | PNEUMOCYSTIS CARINII | 289 | 66% | 2% | 267 | Search PNEUMOCYSTIS+CARINII | Search PNEUMOCYSTIS+CARINII |
3 | PNEUMOCYSTIS JIROVECII | 236 | 86% | 1% | 121 | Search PNEUMOCYSTIS+JIROVECII | Search PNEUMOCYSTIS+JIROVECII |
4 | PNEUMOCYSTIS CARINII PNEUMONIA | 164 | 58% | 1% | 188 | Search PNEUMOCYSTIS+CARINII+PNEUMONIA | Search PNEUMOCYSTIS+CARINII+PNEUMONIA |
5 | PNEUMOCYSTIS PNEUMONIA | 158 | 74% | 1% | 116 | Search PNEUMOCYSTIS+PNEUMONIA | Search PNEUMOCYSTIS+PNEUMONIA |
6 | PNEUMOCYSTIS | 139 | 70% | 1% | 117 | Search PNEUMOCYSTIS | Search PNEUMOCYSTIS |
7 | HIV INFECTION | 113 | 16% | 4% | 639 | Search HIV+INFECTION | Search HIV+INFECTION |
8 | HIV ASSOCIATED NEPHROPATHY | 110 | 78% | 0% | 72 | Search HIV+ASSOCIATED+NEPHROPATHY | Search HIV+ASSOCIATED+NEPHROPATHY |
9 | ANTIRETROVIRAL THERAPY | 83 | 14% | 3% | 573 | Search ANTIRETROVIRAL+THERAPY | Search ANTIRETROVIRAL+THERAPY |
10 | LIPOATROPHY | 82 | 53% | 1% | 110 | Search LIPOATROPHY | Search LIPOATROPHY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARINII PNEUMONIA | 1109 | 82% | 4% | 641 |
2 | ACQUIRED IMMUNODEFICIENCY SYNDROME | 339 | 17% | 10% | 1786 |
3 | LIPODYSTROPHY | 327 | 45% | 3% | 549 |
4 | F SP HOMINIS | 267 | 93% | 1% | 102 |
5 | ACTIVE ANTIRETROVIRAL THERAPY | 242 | 14% | 9% | 1579 |
6 | FAT REDISTRIBUTION | 225 | 92% | 1% | 90 |
7 | AEROSOLIZED PENTAMIDINE | 223 | 64% | 1% | 219 |
8 | IMMUNE DEFICIENCY SYNDROME | 220 | 21% | 5% | 950 |
9 | ANTIRETROVIRAL THERAPY | 190 | 12% | 9% | 1496 |
10 | JIROVECII PNEUMONIA | 177 | 87% | 1% | 87 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HIV MEDICINE | 52 | 22% | 1% | 213 |
2 | JOURNAL OF EUKARYOTIC MICROBIOLOGY | 40 | 13% | 2% | 293 |
3 | HIV CLINICAL TRIALS | 18 | 19% | 1% | 88 |
4 | AIDS PATIENT CARE AND STDS | 17 | 10% | 1% | 156 |
5 | CURRENT OPINION IN HIV AND AIDS | 8 | 10% | 0% | 72 |
6 | AIDS REVIEWS | 5 | 14% | 0% | 35 |
7 | AIDS RESEARCH AND THERAPY | 4 | 13% | 0% | 30 |
8 | AIDS READER | 4 | 18% | 0% | 19 |
9 | CURRENT HIV/AIDS REPORTS | 4 | 14% | 0% | 24 |
10 | AIDS PATIENT CARE | 3 | 14% | 0% | 21 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Stimulating High Impact HIV-Related Cardiovascular Research Recommendations From a Multidisciplinary NHLBI Working Group on HIV-Related Heart, Lung, and Blood Disease | 2015 | 2 | 42 | 83% |
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review | 2006 | 299 | 36 | 86% |
Pneumocystis pneumonia | 2004 | 318 | 101 | 93% |
Colonization by Pneumocystis jirovecii and Its Role in Disease | 2012 | 56 | 286 | 91% |
Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America | 2005 | 332 | 167 | 71% |
The end of AIDS: HIV infection as a chronic disease | 2013 | 99 | 82 | 32% |
Microbial translocation in HIV infection: causes, consequences and treatment opportunities | 2012 | 93 | 150 | 42% |
HIV infection and cardiovascular disease | 2014 | 9 | 75 | 80% |
Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence | 2011 | 82 | 57 | 65% |
B cells in HIV infection and disease | 2009 | 229 | 114 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRAM NUTR METAB | 74 | 62% | 0.4% | 76 |
2 | HIV MOL GRP | 21 | 71% | 0.1% | 17 |
3 | PARASITOL MYCOL TRAVEL MED | 20 | 100% | 0.1% | 9 |
4 | CLIN DOENCAS INFECCIOSAS | 19 | 74% | 0.1% | 14 |
5 | PULM CRIT CARE INTERNAL MED | 15 | 48% | 0.1% | 23 |
6 | UNIDADE PROTOZOARIOS OPORTUNISTAS VIH OUTRAS PR | 14 | 57% | 0.1% | 17 |
7 | NUTR INFECT UNIT | 14 | 55% | 0.1% | 17 |
8 | THORAC DIS UNIT | 13 | 24% | 0.3% | 50 |
9 | AHOD | 11 | 100% | 0.0% | 6 |
10 | EA3609 | 10 | 61% | 0.1% | 11 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000006625 | VIROLOGY//AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1 |
2 | 0.0000003391 | TOXOPLASMA GONDII//NEOSPORA CANINUM//CRYPTOSPORIDIUM |
3 | 0.0000002345 | VIROLOGY//CYTOMEGALOVIRUS//EPSTEIN BARR VIRUS |
4 | 0.0000001964 | MYCOSES//MEDICAL MYCOLOGY//MYCOLOGY |
5 | 0.0000001949 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS |
6 | 0.0000001758 | TOXIC EPIDERMAL NECROLYSIS//STEVENS JOHNSON SYNDROME//DRUG HYPERSENSITIVITY |
7 | 0.0000001669 | HEPATITIS C VIRUS//HEPATITIS B VIRUS//HEPATITIS C |
8 | 0.0000001636 | STREPTOCOCCUS PNEUMONIAE//NEISSERIA MENINGITIDIS//COMMUNITY ACQUIRED PNEUMONIA |
9 | 0.0000001391 | BEHCETS DISEASE//WEGENERS GRANULOMATOSIS//GIANT CELL ARTERITIS |
10 | 0.0000001153 | SEXUALLY TRANSMITTED DISEASES//SEXUALLY TRANSMITTED INFECTIONS//AIDS AND BEHAVIOR |